Peripheral blood stem cell transplantation improves liver functional reserve

Area of Science:

• Hepatology
• Regenerative Medicine
• Transplantation Immunology

Background:

• Limited efficacy of current treatments for decompensated hepatitis B-induced liver cirrhosis.
• Stem cell transplantation is an emerging therapeutic strategy for liver cirrhosis.
• Need for effective interventions to improve liver functional reserve in hepatitis B patients.

Purpose of the Study:

• To evaluate the efficacy of autologous peripheral blood stem cell transplantation in enhancing liver functional reserve.
• To assess the impact of stem cell transplantation on clinical symptoms in patients with hepatitis B-induced cirrhosis.

Main Methods:

• A study involving 51 patients with hepatitis B-induced liver cirrhosis.
• Patients were divided into a treatment group (n=23) receiving stem cell transplantation and a control group (n=28) receiving standard care.
• Liver functional reserve was monitored for 48 weeks post-transplantation.

Main Results:

• Significant improvement in liver functional reserve indicated by a decrease in indocyanine green retention rate at 15 minutes (41.99±4.68 to 37.79±3.75).
• Most patients in the treatment group experienced symptom relief, including reduced fatigue, anorexia, and abdominal distension.

Conclusions:

• Autologous peripheral blood stem cell transplantation is a promising treatment for hepatitis B-induced liver cirrhosis.
• The procedure demonstrates potential for improving liver health markers and functional reserve.
• Further clinical application of this regenerative therapy is warranted.